CARBOPLATIN Safety Questions, CARBOPLATIN Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about CARBOPLATIN. Our extensive database of CARBOPLATIN adverse events and CARBOPLATIN warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about CARBOPLATIN
CARBOPLATIN Safety Reports
Total CARBOPLATIN reports: 670.CARBOPLATIN FDA safety alerts: No.
Reported deaths: 103 Reported hospitalizations: 377.
Take CARBOPLATIN Side Effects Survey or Share Your CARBOPLATIN Story. CARBOPLATIN Usage.
Showing 1-50 of 670 Next >
Consumer or non-health professional from NORWAY reported CARBOPLATIN problem on Jan 26, 2007. Female patient, 74 years of age, was diagnosed with lung cancer metastatic and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: atrial flutter, hypotension, neutropenic sepsis. CARBOPLATIN dosage: 540 MG ONCE IV. During the same period patient was treated with ETOPOSIDE. Patient died on 12/15/2006.CARBOPLATIN problem was reported by a Consumer or non-health professional from BELGIUM on Jan 26, 2007. Female patient, child 4 years of age, was diagnosed with neuroblastoma and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, gene mutation, infection, neoplasm recurrence, neuroblastoma, stem cell transplant. CARBOPLATIN dosage: 750 MG/M2 OTH. During the same period patient was treated with ETOPOSIDE, CISPLATIN, DOXORUBICIN, DACARBAZINE, ONCOVIN, CYCLOPHOSPHAMIDE, BUSULFAN, MELPHALAN. Patient died.
Consumer or non-health professional from UNITED STATES reported CARBOPLATIN problem on Feb 09, 2007. Female patient, weighting 107.1 lb, was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: neutropenia. CARBOPLATIN dosage: 800 MG. During the same period patient was treated with TAXOL. Patient recovered.
CARBOPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 08, 2007. Male patient, 80 years of age, weighting 158.7 lb, was diagnosed with small cell lung cancer extensive stage, hypertension, hypolipidaemia, constipation and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: dehydration, diarrhoea. CARBOPLATIN dosage: unknown. During the same period patient was treated with PEMETREXED DI, DILTIAZEM CD, INDAPAMID, ATORVASTATIN, COLOXYL, CALCIUM CARBONATE, FOLIC ACID, ASPIRIN. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported CARBOPLATIN problem on Feb 14, 2007. Male patient, weighting 147.7 lb, was diagnosed with laryngeal cancer and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: chest discomfort, cough, dyspnoea, infusion related reaction, oxygen saturation decreased. CARBOPLATIN dosage: 160MG WEEKLY X3 Q4WEEKS. During the same period patient was treated with TAXOL. Patient recovered.
CARBOPLATIN problem was reported by a Physician from UNITED STATES on Feb 14, 2007. Female patient, 57 years of age, weighting 131.0 lb, was diagnosed with laryngeal cancer and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: agitation, dehydration, dyspnoea, haemoptysis, iatrogenic injury, leukopenia, neutropenia, pyrexia, thrombocytopenia. CARBOPLATIN dosage: 400 MG ONCE Q 4 WKS IV. During the same period patient was treated with TAXOTERE, IFOSFAMIDE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported CARBOPLATIN problem on Feb 12, 2007. Female patient, weighting 125.7 lb, was diagnosed with endometrial cancer recurrent, endometrial cancer stage iv and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: activities of daily living impaired, mucosal inflammation, neutropenia, perineal pain, skin exfoliation, skin ulcer. CARBOPLATIN dosage: 579 MG. During the same period patient was treated with TAXOL. Patient recovered.
CARBOPLATIN problem was reported by a Health Professional from UNITED STATES on Feb 15, 2007. Female patient, 45 years of age, weighting 150.4 lb, was diagnosed with lung neoplasm malignant and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: pneumonectomy. CARBOPLATIN dosage: unknown. During the same period patient was treated with TAXOL, WELLBUTRIN, COMPAZINE, PERCOCET. Patient was hospitalized. Patient died on 02/13/2007.
Consumer or non-health professional from UNITED STATES reported CARBOPLATIN problem on Feb 16, 2007. Male patient, 55 years of age, weighting 187.4 lb, was diagnosed with bronchitis, prophylaxis, back pain, thrombosis prophylaxis and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: lung abscess, pancytopenia, pyothorax, sepsis. CARBOPLATIN dosage: unknown. During the same period patient was treated with ETOPOSIDE, THEOPHYLLINE, PANTOPRAZOLE, NAPROXEN, NADROPARIN CALCIUM, AMBROXOL. Patient was hospitalized. Patient died on 11/29/2006.
CARBOPLATIN problem was reported by a Pharmacist from UNITED STATES on Feb 16, 2007. Male patient, 67 years of age, was diagnosed with neoplasm malignant and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: neutropenia. CARBOPLATIN dosage: 350ML. During the same period patient was treated with GEMCITABINE, FLUCONAZOLE, OXYCODONE, LISINOPRIL, GLYBURIDE, FUROSEMIDE, EPOETIN, GABAPENTIN. Patient was hospitalized. Patient recovered.
Health Professional from FRANCE reported CARBOPLATIN problem on Jan 29, 2007. Female patient, 67 years of age, weighting 125.7 lb, was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: bone marrow failure, neuropathy, pancytopenia, purpura. CARBOPLATIN dosage: unknown. During the same period patient was treated with TAXOL, EFFEXOR. Patient was hospitalized. Patient recovered.
CARBOPLATIN problem was reported by a Health Professional from FRANCE on Jan 30, 2007. Female patient, 48 years of age, weighting 165.3 lb, was diagnosed with ovarian cancer and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock, rash. CARBOPLATIN dosage: 550 MG FREQ IV. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported CARBOPLATIN problem on Feb 20, 2007. Male patient, weighting 121.3 lb, was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: diarrhoea, neutrophil count decreased. CARBOPLATIN dosage: 425.76 MG. During the same period patient was treated with PACLITAXEL, KEFLEX. Patient was hospitalized. Patient recovered.
CARBOPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 21, 2007. Female patient, weighting 224.9 lb, was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, diarrhoea, disease progression, large intestinal obstruction, pulmonary embolism, sepsis. CARBOPLATIN dosage: 459 MG. During the same period patient was treated with TAXOL. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported CARBOPLATIN problem on Feb 21, 2007. Female patient, weighting 142.2 lb, was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: neutrophil count decreased. CARBOPLATIN dosage: 513 MG. During the same period patient was treated with TAXOL. Patient was hospitalized. Patient recovered.
CARBOPLATIN problem was reported by a Consumer or non-health professional from ITALY on Feb 14, 2007. Female patient, 68 years of age, was diagnosed with ovarian cancer metastatic and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: angina pectoris, cardiac arrest. CARBOPLATIN dosage: 450 MG (10 MG/ML) INTRAVENOUS (NOT OTHERWISE SPECIFIED). During the same period patient was treated with CHLORIDE, DILTIAZEM HYDROCHLORIDE, ANTIEMETICS AND ANTINAUSEANTS, CORTICOSTEROIDS NOS, ANTIHISTAMINES. Patient recovered.
Health Professional from GERMANY reported CARBOPLATIN problem on Feb 16, 2007. Female patient, 63 years of age, was diagnosed with non-small cell lung cancer, chronic obstructive pulmonary disease and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: constipation, febrile neutropenia, ileus. CARBOPLATIN dosage: unknown. During the same period patient was treated with PACLITAXEL, ZOFRAN, FLOVENT, SEREVENT, ALBUTEROL, SPIRIVA. Patient was hospitalized. Patient recovered.
CARBOPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 27, 2007. Female patient, weighting 130.1 lb, was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: cerebral haemorrhage, cerebrovascular accident, tremor. CARBOPLATIN dosage: 100 MG. During the same period patient was treated with PACLITAXEL, VIT D, CALCIUM, IBUPROFEN. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported CARBOPLATIN problem on Feb 27, 2007. Female patient, weighting 105.4 lb, was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: neutropenia. CARBOPLATIN dosage: unknown. During the same period patient was treated with TAXOL. Patient was hospitalized. Patient recovered.
CARBOPLATIN problem was reported by a Consumer or non-health professional from GERMANY on Feb 12, 2007. Male patient, 65 years of age, was diagnosed with mantle cell lymphoma and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: arrhythmia supraventricular, haemoglobin decreased, paroxysmal arrhythmia, pericarditis, platelet count decreased, white blood cell count decreased. CARBOPLATIN dosage: unknown. During the same period patient was treated with ETOPOSIDE, TREOSULFAN. Patient recovered.
Consumer or non-health professional from FRANCE reported CARBOPLATIN problem on Feb 12, 2007. Male patient, 67 years of age, weighting 154.3 lb, was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: anaemia, rectal haemorrhage, thrombocytopenia. CARBOPLATIN dosage: 500 MG PER_CYCLE IV. During the same period patient was treated with GEMZAR. Patient was hospitalized. Patient recovered.
CARBOPLATIN problem was reported by a Consumer or non-health professional from FRANCE on Feb 09, 2007. Male patient, 55 years of age, weighting 154.3 lb, was diagnosed with b-cell lymphoma and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: confusional state, disorientation, paranoia. CARBOPLATIN dosage: 680 MG FREQ IV. During the same period patient was treated with HOLOXAN, UROMITEXAN, ETOPOSIDE, MABTHERA. Patient was hospitalized. Patient recovered.
Health Professional from UNITED STATES reported CARBOPLATIN problem on Jan 03, 2007. Female patient, 80 years of age, weighting 106.0 lb, was diagnosed with ovarian cancer and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: hypotension, nausea, pruritus. CARBOPLATIN dosage: 350MG/IV/Q3WKS. During the same period patient was treated with SYNTHROID, ACIPHEX, TAXOTERE, DECADRON. Patient recovered.
CARBOPLATIN problem was reported by a Physician from UNITED STATES on Jan 10, 2007. Female patient was diagnosed with ovarian cancer and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: hypersensitivity. CARBOPLATIN dosage: 440MG/IV/Q21DAYS. During the same period patient was treated with GEMZAR. Patient recovered.
Physician from UNITED STATES reported CARBOPLATIN problem on Oct 31, 2006. Female patient, 81 years of age, weighting 138.9 lb, was diagnosed with ovarian cancer and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: neuropathy, tinnitus. CARBOPLATIN dosage: unknown. During the same period patient was treated with TAXOL. Patient recovered.
CARBOPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 22, 2007. Male patient, 62 years of age, was diagnosed with lung cancer metastatic, pain and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: confusional state, fatigue, malignant neoplasm progression. CARBOPLATIN dosage: unknown. During the same period patient was treated with PACLITAXEL, TIAZAC, LEXAPRO, PROTONIX, FENTANYL TRANSDERMAL SYSTEM, DILAUDID, MUCOMYST. Patient was hospitalized. Patient died on 10/13/2006.
Health Professional from GERMANY reported CARBOPLATIN problem on Feb 28, 2007. Female patient, 63 years of age, was diagnosed with non-small cell lung cancer, chronic obstructive pulmonary disease and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: constipation, febrile neutropenia, ileus. CARBOPLATIN dosage: unknown. During the same period patient was treated with PACLITAXEL, ZOFRAN, FLOVENT, SEREVENT, ALBUTEROL, SPIRIVA. Patient was hospitalized. Patient recovered.
CARBOPLATIN problem was reported by a Pharmacist from UNITED STATES on Mar 02, 2007. Female patient was diagnosed with ovarian cancer recurrent and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: chest discomfort, crepitations, feeling hot, infusion related reaction, nausea, wheezing. CARBOPLATIN dosage: unknown. Patient recovered.
Consumer or non-health professional from UNITED STATES reported CARBOPLATIN problem on Mar 02, 2007. Female patient, weighting 172.0 lb, was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: dysphagia, febrile neutropenia, oesophagitis. CARBOPLATIN dosage: 507 MG. During the same period patient was treated with ETOPOSIDE. Patient was hospitalized. Patient recovered.
CARBOPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 05, 2007. Female patient, weighting 271.2 lb, was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: neutrophil count decreased. CARBOPLATIN dosage: 610 MG. During the same period patient was treated with TAXOL. Patient recovered.
Consumer or non-health professional from FRANCE reported CARBOPLATIN problem on Feb 22, 2007. Male patient, 55 years of age, was diagnosed with lymphoma and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: confusional state, disorientation, paranoia. CARBOPLATIN dosage: 680 MG INTRAVENOUS. During the same period patient was treated with IFOSFAMIDE, MESNA, ETOPOSIDE, RITUXIMAB. Patient was hospitalized. Patient recovered.
CARBOPLATIN problem was reported by a Consumer or non-health professional from COLOMBIA on Feb 13, 2007. Female patient, 32 years of age, was diagnosed with ovarian cancer and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: alopecia, pruritus, pyrexia, toxic skin eruption, vasculitis. CARBOPLATIN dosage: 450 MG INTRAVENOUS. During the same period patient was treated with PACLITAXEL, ONDANSETRON. Patient recovered.
Consumer or non-health professional from UNITED STATES reported CARBOPLATIN problem on Mar 06, 2007. Female patient, weighting 105.4 lb, was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: neutropenia. CARBOPLATIN dosage: 800 MG. During the same period patient was treated with TAXOL. Patient recovered.
CARBOPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 07, 2007. Male patient, weighting 121.3 lb, was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: diarrhoea, metastatic malignant melanoma, neutrophil count decreased. CARBOPLATIN dosage: 425.76 MG. During the same period patient was treated with PACLITAXEL, KEFLEX. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported CARBOPLATIN problem on Mar 07, 2007. Female patient, weighting 173.3 lb, was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: fatigue, neuropathy, neutropenia. CARBOPLATIN dosage: 515 MG. During the same period patient was treated with TAXOL. Patient recovered.
CARBOPLATIN problem was reported by a Health Professional from UNITED KINGDOM on Mar 06, 2007. Female patient, 49 years of age, was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: encephalopathy, grand mal convulsion, visual disturbance. CARBOPLATIN dosage: unknown. During the same period patient was treated with CISPLATIN, ETOPOSIDE, TAXOL, GEMCITABINE, PROPOFOL, FENTANYL, MORPHINE, PROPRANOLOL. Patient recovered.
Consumer or non-health professional from UNITED STATES reported CARBOPLATIN problem on Mar 07, 2007. Male patient, 70 years of age, was diagnosed with non-small cell lung cancer and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: gastrointestinal haemorrhage. CARBOPLATIN dosage: unknown. During the same period patient was treated with DOCETAXEL, NORVASC, LASIX, PREDNISONE, ALTACE, TOPROL, PLAQUENIL. Patient was hospitalized. Patient recovered.
CARBOPLATIN problem was reported by a Consumer or non-health professional from ITALY on Feb 28, 2007. Female patient, 68 years of age, was diagnosed with ovarian cancer metastatic and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: angina pectoris, atrioventricular block, cardiac arrest, electrocardiogram abnormal, prinzmetal angina. CARBOPLATIN dosage: 450 MG (10 MG/ML) INTRAVENOUS (NOT OTHERWISE SPECIFIED). During the same period patient was treated with CHLORIDE, DILTIAZEM HYDROCHLORIDE, ANTIEMETICS AND ANTINAUSEANTS, CORTICOSTEROID NOS. Patient recovered.
Health Professional from FRANCE reported CARBOPLATIN problem on Mar 12, 2007. Female patient, 53 years of age, was diagnosed with lung cancer metastatic and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, creatinine renal clearance decreased, hypomagnesaemia, hypophosphataemia, neutropenia, reversible posterior leukoencephalopathy syndrome, thrombocytopenia. CARBOPLATIN dosage: unknown. During the same period patient was treated with CISPLATIN, GEMCITABINE. Patient was hospitalized. Patient recovered.
CARBOPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 13, 2007. Male patient, 56 years of age, was diagnosed with non-small cell lung cancer and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: chronic obstructive pulmonary disease, hypomagnesaemia, pleural effusion. CARBOPLATIN dosage: unknown. During the same period patient was treated with TAXOL. Patient was hospitalized. Patient recovered.
Health Professional from GERMANY reported CARBOPLATIN problem on Mar 09, 2007. Male patient, 77 years of age, was diagnosed with non-small cell lung cancer, medical diet, peptic ulcer, neuropathy peripheral, pain and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: acute respiratory failure, malignant neoplasm progression, pleural effusion. CARBOPLATIN dosage: unknown. During the same period patient was treated with PACLITAXEL, ZANTAC, VITAMIN B6, LYRICA, HYDROCODONE. Patient was hospitalized. Patient died on 01/16/2007.
CARBOPLATIN problem was reported by a Health Professional from GERMANY on Mar 08, 2007. Male patient, 74 years of age, was diagnosed with non-small cell lung cancer and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: epistaxis, thrombocytopenia. CARBOPLATIN dosage: unknown. During the same period patient was treated with CETUXIMAB, GEMCITABINE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported CARBOPLATIN problem on Mar 13, 2007. Male patient, 56 years of age, was diagnosed with non-small cell lung cancer and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: chronic obstructive pulmonary disease, hypomagnesaemia, pleural effusion. CARBOPLATIN dosage: unknown. During the same period patient was treated with TAXOL. Patient was hospitalized. Patient recovered.
CARBOPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 14, 2007. Female patient, weighting 149.9 lb, was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: neutrophil count abnormal. CARBOPLATIN dosage: 372 MG. During the same period patient was treated with TAXOL, COMPAZINE, COUMADIN, DECADRON, OXYCONTIN, PERCOCET, ZANTAC. Patient recovered.
Consumer or non-health professional from UNITED STATES reported CARBOPLATIN problem on Mar 14, 2007. Female patient, weighting 147.3 lb, was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: neutrophil count decreased. CARBOPLATIN dosage: 513 MG. During the same period patient was treated with TAXOL. Patient recovered.
CARBOPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 15, 2007. Female patient, weighting 125.7 lb, was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: anaemia, neutrophil count decreased, rectal haemorrhage, white blood cell count decreased. CARBOPLATIN dosage: 794 MG. During the same period patient was treated with TAXOL. Patient was hospitalized. Patient recovered.
Health Professional from FRANCE reported CARBOPLATIN problem on Mar 19, 2007. Female patient, 53 years of age, was diagnosed with lung cancer metastatic and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, creatinine renal clearance decreased, hypomagnesaemia, hypophosphataemia, neutropenia, reversible posterior leukoencephalopathy syndrome, thrombocytopenia. CARBOPLATIN dosage: unknown. During the same period patient was treated with CISPLATIN, GEMCITABINE. Patient was hospitalized. Patient recovered.
CARBOPLATIN problem was reported by a Consumer or non-health professional from JAPAN on Feb 28, 2007. Male patient, 58 years of age, was diagnosed with thymoma and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: myocarditis, polymyositis. CARBOPLATIN dosage: 550 MG; TWO COURSES. During the same period patient was treated with TAXOL. Patient died.
Consumer or non-health professional from GERMANY reported CARBOPLATIN problem on Feb 28, 2007. Male patient, 29 years of age, was diagnosed with testicular cancer metastatic and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, cardiac tamponade, dehydration, dialysis, heart rate increased, hypotension, pericarditis, renal failure acute, renal tubular disorder. CARBOPLATIN dosage: 1250 MG DAILY. During the same period patient was treated with ETOPOSIDE, CYCLOPHOSPHAMIDE, ZOFRAN, DUSSELDORF BLANDING, MESNA, FORTUM, MYCOSTATIN, PARACET. Patient died on 10/17/2006.
CARBOPLATIN problem was reported by a Health Professional from NORWAY on Feb 28, 2007. Female patient, 60 years of age, was diagnosed with ovarian cancer and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: defaecation urgency, flushing, heart rate increased, hypersensitivity, hypotension, vomiting. CARBOPLATIN dosage: 450 MG DAILY IV. During the same period patient was treated with PACLITAXEL. Patient recovered.
Showing 1-50 of 670 Next >